Wyche Green - Streamline Health Director
| STRM Stock | USD 0.36 0.03 9.09% |
Director
Mr. Wyche T. Green, III is President, Chief Executive Officer, Director of the Company. He is the Chairman and Chief Executive Officer of Greenway Unlimited, an investment company that he founded in 2013. He is the former Chief Executive Officer and Executive Chairman, and a cofounder, of Greenway Medical Health, an electronic health record and practice management based in Carrollton, Georgia, where he served in leadership roles since 1998 and was responsible for leading the Companys strategic direction while managing the sales, marketing and business development teams. He has a wide array of public and nonpublic board service with healthcare and technology related companies since 2019.
| Age | 45 |
| Tenure | 5 years |
| Address | 2400 Old Milton Pkwy, Alpharetta, GA, United States, 30009 |
| Phone | 888 997 8732 |
| Web | https://www.streamlinehealth.net |
Wyche Green Latest Insider Activity
Tracking and analyzing the buying and selling activities of Wyche Green against Streamline Health stock is an integral part of due diligence when investing in Streamline Health. Wyche Green insider activity provides valuable insight into whether Streamline Health is net buyers or sellers over its current business cycle. Note, Streamline Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Streamline Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Wyche Green over three weeks ago Acquisition by Wyche Green of 921053 shares of Streamline Health at 0.38 subject to Rule 16b-3 |
Streamline Health Management Efficiency
The company has return on total asset (ROA) of (0.1144) % which means that it has lost $0.1144 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7237) %, meaning that it created substantial loss on money invested by shareholders. Streamline Health's management efficiency ratios could be used to measure how well Streamline Health manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of April 2024, Return On Tangible Assets is likely to grow to -0.7. In addition to that, Return On Capital Employed is likely to grow to -0.26. At this time, Streamline Health's Total Assets are very stable compared to the past year. As of the 19th of April 2024, Non Current Assets Total is likely to grow to about 55 M, while Total Current Assets are likely to drop about 12.8 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Frank Corvino | HealthEquity | 68 | |
| Ian Sacks | R1 RCM Inc | 47 | |
| Joseph Impicciche | R1 RCM Inc | 60 | |
| Charles Ditkoff | R1 RCM Inc | 55 | |
| James Bryant | 10X Genomics | N/A | |
| Frank Medici | HealthEquity | 53 | |
| Alex Mandl | R1 RCM Inc | 74 | |
| Adrian Dillon | HealthEquity | 63 | |
| Ian Sacks | HealthEquity | 47 | |
| Anthony Speranzo | R1 RCM Inc | 69 | |
| Nikhil Rao | 10X Genomics | N/A | |
| Jill Smith | R1 RCM Inc | 59 | |
| Manu Rana | HealthEquity | 45 | |
| Albert Zimmerli | R1 RCM Inc | 66 | |
| Gayle Wellborn | HealthEquity | 56 | |
| Debra McCowan | HealthEquity | 46 | |
| Evelyn Dilsaver | HealthEquity | 62 | |
| John Henneman | R1 RCM Inc | 56 | |
| Neal Moszkowski | R1 RCM Inc | 52 | |
| Michael Feiner | R1 RCM Inc | 75 | |
| Michael Leavitt | HealthEquity | 66 | |
Management Performance
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 |
Streamline Health Leadership Team
Elected by the shareholders, the Streamline Health's board of directors comprises two types of representatives: Streamline Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Streamline. The board's role is to monitor Streamline Health's management team and ensure that shareholders' interests are well served. Streamline Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Streamline Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Stilwill, President | ||
| Donald Vick, Director Analytics | ||
| Jawad Shaikh, Chief Officer | ||
| Wyche Green, Director | ||
| David Sides, CEO and President and Director | ||
| Jacob Goldberger, Director FPA | ||
| Wendy Lucio, Chief Officer | ||
| Wendy Lovvorn, Chief Officer | ||
| Lois Rickard, Chief People Officer and Sr. VP | ||
| Luciana Mullen, Principal Accounting Officer | ||
| Amy Sebero, Chief Officer | ||
| Shaun Priest, Senior Vice President and Chief Growth Officer | ||
| Bryant Reeves, Interim Staff | ||
| Wyche III, Executive Chairman | ||
| Jack Kennedy, Chief Legal Counsel and Sr. VP of Admin. | ||
| Lance Seach, Senior Development | ||
| Kenan Lucas, Director | ||
| Nicholas Meeks, CFO, Senior Vice President | ||
| Michael Valentine, Independent Director | ||
| Allen Moseley, Independent Director | ||
| Randolph Salisbury, Chief Marketing Officer and Sr. VP | ||
| Jonathan Phillips, Independent Chairman of the Board | ||
| Benjamin Stilwill, Chief Officer | ||
| William Garvis, COO, Senior Vice President | ||
| Michael Kaplan, Independent Director | ||
| Judith Starkey, Director | ||
| Thomas Gibson, CFO, Senior Vice President | ||
| MB CCS, VP eValuator |
Streamline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Streamline Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.81) % | ||||
| Operating Margin | (0.71) % | ||||
| Current Valuation | (1.85 M) | ||||
| Shares Outstanding | 59.09 M | ||||
| Shares Owned By Insiders | 28.21 % | ||||
| Shares Owned By Institutions | 31.81 % | ||||
| Number Of Shares Shorted | 58.15 K | ||||
| Price To Earning | 321.67 X |
Currently Active Assets on Macroaxis
When determining whether Streamline Health is a strong investment it is important to analyze Streamline Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Streamline Health's future performance. For an informed investment choice regarding Streamline Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Streamline Stock analysis
When running Streamline Health's price analysis, check to measure Streamline Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Streamline Health is operating at the current time. Most of Streamline Health's value examination focuses on studying past and present price action to predict the probability of Streamline Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Streamline Health's price. Additionally, you may evaluate how the addition of Streamline Health to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Streamline Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (0.35) | Revenue Per Share 0.428 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.